계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Entelos
company
About
Entelos is a provider of predictive biosimulation for drug discovery and development.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $25M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 1996
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Entelos is the leading provider of predictive biosimulation for drug discovery and development. We provide advanced biosimulation capabilities that make discovery more efficient and increase clinical success.For over 15 years, we have enabled R&D organizations to predict better paths to success by simulating systems biology. Our solutions include mechanism-based, mathematical models; virtual patients and populations; biosimulation software; and biosimulation expertise.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$25M
Entelos has raised a total of
$25M
in funding over 2 rounds. Their latest funding was raised on
Sep 6, 2001 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 6, 2001 | Series C | $25M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Entelos is funded by 1 investors.
Bear Stearns Health Innoventures L.P
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
